Saporin immunotoxins have been well described and successful at targeting VLC[15,19] Anti-murine CD52-saporin was administered to tumor bearing mice twice-weekly for three weeks and then animals were sacrificed 24 hours after the last administration of the immunotoxin. This evidence concerns the gene CD52 and neoplasm.